Midostaurin in addition to intensive chemotherapy in acute myeloid leukemia with t(8;21) and KIT and/or FLT3-ITD mutations: results of the SAL MIDOKIT trial

被引：3

作者：

Ruhnke, Leo ^{[1
]}

Roellig, Christoph ^{[1
]}

Herold, Sylvia ^{[2
]}

Sauer, Tim ^{[3
,4
,5
]}

Brandts, Christian H. ^{[7
]}

Steffen, Bjoern ^{[6
]}

Schaefer-Eckart, Kerstin ^{[7
]}

Krause, Stefan W. ^{[8
]}

Haenel, Mathias ^{[9
]}

Reichle, Albrecht ^{[10
]}

Scholl, Sebastian ^{[11
]}

Neubauer, Andreas ^{[12
]}

Mikesch, Jan-Henrik ^{[13
]}

Schetelig, Johannes ^{[1
,14
]}

Stoelzel, Friedrich ^{[1
]}

Kramer, Michael ^{[1
]}

Haake, Annett ^{[1
]}

Frimmel, Julia ^{[1
]}

Kraemer, Alwin ^{[3
,4
,5
]}

Schlenk, Richard ^{[3
,4
,5
]}

Platzbecker, Uwe ^{[15
]}

Serve, Hubert ^{[6
]}

Baldus, Claudia D. ^{[16
]}

Mueller-Tidow, Carsten ^{[3
]}

Aust, Daniela ^{[2
]}

Bornhaeuser, Martin ^{[1
,4
,5
,17
]}

Ehninger, Gerhard ^{[1
]}

Thiede, Christian ^{[1
,18
]}

机构：

[1] Tech Univ Dresden, Univ Hosp Dresden, Dept Internal Med 1, Dresden, Germany

[2] Univ Hosp Dresden, Inst Pathol, Dresden, Germany

[3] Heidelberg Univ, Dept Internal Med 5, Heidelberg, Germany

[4] German Canc Consortium DKTK, Partner Site Dresden, Heidelberg, Germany

[5] German Canc Res Ctr, Heidelberg, Germany

[6] Univ Hosp Frankfurt, Dept Internal Med 2, Frankfurt, Germany

[7] Paracelsus Med Univ, Nuremberg Hosp North, Dept Internal Med 5, Nurnberg, Germany

[8] Univ Hosp Erlangen, Dept Internal Med 5, Erlangen, Germany

[9] Chemnitz Hosp, Dept Internal Med 3, Chemnitz, Germany

[10] Univ Hosp Regensburg, Dept Internal Med Hematol & Internal Oncol 3, Regensburg, Germany

[11] Univ Hosp Jena, Dept Internal Med Hematol & Internal Oncol 2, Jena, Germany

[12] Univ Hosp Marburg, Dept Internal Med Hematol Oncol & Immunol, Marburg, Germany

[13] Univ Hosp Munster, Dept Internal Med A, Munster, Germany

[14] DKMS Clin Trials Unit, Dresden, Germany

[15] Univ Hosp Leipzig, Dept Internal Med Hematol & Cellular Therapy 1, Leipzig, Germany

[16] Univ Hosp Schleswig Holstein, Dept Hematol & Oncol, Campus Kiel, Kiel, Germany

[17] Natl Ctr Tumor Dis NCT Dresden, Dresden, Germany

[18] Agendix GmbH, Dresden, Germany

来源：

HAEMATOLOGICA | 2023年 / 108卷 / 09期

关键词：

INV(16); CANCER; ADULTS;

D O I：

10.3324/haematol.2022.281636

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

页码：2520 / 2525

页数：6

共 15 条

[1] The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia [J].

Arber, Daniel A. ;

Orazi, Attilio ;

Hasserjian, Robert ;

Thiele, Jurgen ;

Borowitz, Michael J. ;

Le Beau, Michelle M. ;

Bloomfield, Clara D. ;

Cazzola, Mario ;

Vardiman, James W. .

BLOOD, 2016, 127 (20) :2391-2405

[2] Prognostic impact of c-KIT mutations in core binding factor leukemas:: an Italian retrospective study [J].

Cairoli, R ;

Beghini, A ;

Grillo, G ;

Nadali, G ;

Elice, F ;

Ripamonti, CB ;

Colapietro, P ;

Nichelatti, M ;

Pezzetti, L ;

Lunghi, M ;

Cuneo, A ;

Viola, A ;

Ferrara, F ;

Lazzarino, M ;

Rodeghiero, F ;

Pizzolo, G ;

Larizza, L ;

Morra, E .

BLOOD, 2006, 107 (09) :3463-3468

[3] Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel [J].

Doehner, Hartmut ;

Estey, Elihu ;

Grimwade, David ;

Amadori, Sergio ;

Appelbaum, Frederick R. ;

Buechner, Thomas ;

Dombret, Herve ;

Ebert, Benjamin L. ;

Fenaux, Pierre ;

Larson, Richard A. ;

Levine, Ross L. ;

Lo-Coco, Francesco ;

Naoe, Tomoki ;

Niederwieser, Dietger ;

Ossenkoppele, Gert J. ;

Sanz, Miguel ;

Sierra, Jorge ;

Tallman, Martin S. ;

Tien, Hwei-Fang ;

Wei, Andrew H. ;

Lowenberg, Bob ;

Bloomfield, Clara D. .

BLOOD, 2017, 129 (04) :424-447

[4] Comprehensive mutational profiling of core binding factor acute myeloid leukemia [J].

Duployez, Nicolas ;

Marceau-Renaut, Alice ;

Boissel, Nicolas ;

Petit, Arnaud ;

Bucci, Maxime ;

Geffroy, Sandrine ;

Lapillonne, Helene ;

Renneville, Aline ;

Ragu, Christine ;

Figeac, Martin ;

Celli-Lebras, Karine ;

Lacombe, Catherine ;

Micol, Jean-Baptiste ;

Abdel-Wahab, Omar ;

Cornillet, Pascale ;

Ifrah, Norbert ;

Dombret, Herve ;

Leverger, Guy ;

Jourdan, Eric ;

Preudhomme, Claude .

BLOOD, 2016, 127 (20) :2451-2459

[5] Molecular landscape of acute myeloid leukemia in younger adults and its clinical relevance [J].

Grimwade, David ;

Ivey, Adam ;

Huntly, Brian J. P. .

BLOOD, 2016, 127 (01) :29-41

[6] Genomic heterogeneity in core-binding factor acute myeloid leukemia and its clinical implication [J].

Jahn, Nikolaus ;

Terzer, Tobias ;

Straeng, Eric ;

Dolnik, Anna ;

Cocciardi, Sibylle ;

Panina, Ekaterina ;

Corbacioglu, Andrea ;

Herzig, Julia ;

Weber, Daniela ;

Schrade, Anika ;

Goetze, Katharina ;

Schroeder, Thomas ;

Luebbert, Michael ;

Wellnitz, Dominique ;

Koller, Elisabeth ;

Schlenk, Richard F. ;

Gaidzik, Verena, I ;

Paschka, Peter ;

Ruecker, Frank G. ;

Heuser, Michael ;

Thol, Felicitas ;

Ganser, Arnold ;

Benner, Axel ;

Doehner, Hartmut ;

Doehner, Konstanze ;

Bullinger, Lars .

BLOOD ADVANCES, 2020, 4 (24) :6342-6352

[7] Prognostic factors and outcome of core binding factor acute myeloid leukemia patients with t(8;21) differ from those of patients with inv(16):: A cancer and leukemia group B study [J].

Marcucci, G ;

Mrózek, K ;

Ruppert, AS ;

Maharry, K ;

Kolitz, JE ;

Moore, JO ;

Mayer, RJ ;

Pettenati, MJ ;

Powell, BL ;

Edwards, CG ;

Sterling, LJ ;

Vardiman, JW ;

Schiffer, CA ;

Carroll, AJ ;

Larson, RA ;

Bloomfield, CD .

JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (24) :5705-5717

[8] Combination of dasatinib with chemotherapy in previously untreated core binding factor acute myeloid leukemia: CALGB 10801 [J].

Marcucci, Guido ;

Geyer, Susan ;

Laumann, Kristina ;

Zhao, Weiqiang ;

Bucci, Donna ;

Uy, Geoffrey L. ;

Blum, William ;

Eisfeld, Ann-Kathrin ;

Pardee, Timothy S. ;

Wang, Eunice S. ;

Stock, Wendy ;

Kolitz, Jonathan E. ;

Kohlschmidt, Jessica ;

Mrozek, Krzysztof ;

Bloomfield, Clara D. ;

Stone, Richard M. ;

Larson, Richard A. .

BLOOD ADVANCES, 2020, 4 (04) :696-705

[9] Adverse prognostic significance of KIT mutations in adult acute myeloid leukemia with inv(16) and t(8;21):: A Cancer and Leukemia Group B study [J].

Paschka, Peter ;

Marcucci, Guido ;

Ruppert, Amy S. ;

Mrozek, Krzysztof ;

Chen, Hankui ;

Kittles, Rick A. ;

Vukosavljevic, Tamara ;

Perrotti, Danilo ;

Vardiman, James W. ;

Carroll, Andrew J. ;

Kolitz, Jonathan E. ;

Larson, Richard A. ;

Bloomfield, Clara D. .

JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (24) :3904-3911

[10] Adding dasatinib to intensive treatment in core-binding factor acute myeloid leukemia-results of the AMLSG 11-08 trial [J].

Paschka, Peter ;

Schlenk, Richard F. ;

Weber, Daniela ;

Benner, Axel ;

Bullinger, Lars ;

Heuser, Michael ;

Gaidzik, Verena I. ;

Thol, Felicitas ;

Agrawal, Mridul ;

Teleanu, Veronica ;

Luebbert, Michael ;

Fiedler, Walter ;

Radsak, Markus ;

Krauter, Juergen ;

Horst, Heinz-A. ;

Greil, Richard ;

Mayer, Karin ;

Kuendgen, Andrea ;

Martens, Uwe ;

Heil, Gerhard ;

Salih, Helmut R. ;

Hertenstein, Bernd ;

Schwaenen, Carsten ;

Wulf, Gerald ;

Lange, Elisabeth ;

Pfreundschuh, Michael ;

Ringhoffer, Mark ;

Girschikofsky, Michael ;

Heinicke, Thomas ;

Kraemer, Doris ;

Goehring, Gudrun ;

Ganser, Arnold ;

Doehner, Konstanze ;

Doehner, Hartmut .

LEUKEMIA, 2018, 32 (07) :1621-1630

← 1 2 →